Human T Cells From Resistant Hypertension Patients Promote Hypertension via TNF in humanized mice
Masudur RahmaniD, Hendrik BartolomaeusiD, Lydia Hering, Mina YakoubiD, Guang YangiD, Johannes Benjamin HolleiD, Lukas StreeseiD, Denada ArifajiD, Milena Hahn, Marta Kantauskaitė, Tim Felix Grüner, Jaroslawna MeisteriD, Nicola WilckiD, Markus KleinewietfeldiD, Lars Christian RumpiD, Dominik N. MülleriD, Sebastian TemmeiD, Johannes StegbaueriD
Abstract
ObjectivePreclinical studies suggest a pivotal role of adaptive immunity, particularly T cells, in hypertension. However, due to the multifactorial pathogenesis, there is still no definitive evidence for a causal role of T cells in the development of hypertension in humans. We sought to determine whether T cells from patients with treatment-resistant hypertension (TRH) directly modulate blood pressure and vascular function in vivo. MethodsPeripheral blood mononuclear cells (PBMCs) from TRH patients and healthy controls (HC) were adoptively transferred into immunodeficient NSG-(KbDb)^null mice. Hypertension was induced by angiotensin II infusion for 14 days and monitored continuously by radiotelemetry. ResultFollowing T cell engraftment, blood pressure was assessed at baseline and during AngII infusion in both groups of recipient mice. At baseline, systolic blood pressure did not differ between both groups. However, mice receiving TRH-PBMCs developed a significantly higher systolic blood pressure following AngII compared with HC-PBMC recipients. Endothelial dysfunction in isolated perfused kidneys was more pronounced in AngII-challenged TRH-PBMC recipients compared to HC-PBMC recipients. TRH-PBMC recipients displayed elevated effector memory CD4 T cells and Th17 frequencies in spleen and kidney, along with markedly increased renal expression of human T cell-derived TNF. Overnight incubation of mouse aortic rings with human TNF induced endothelial dysfunction, indicating a causal role of T cell-derived TNF. As a proof of concept, TNF inhibition attenuated AngII-induced hypertension in TRH-PBMC-engrafted mice. ConclusionT cells from patients with treatment-resistant hypertension promote an exaggerated hypertensive response and endothelial dysfunction in PBMC-engrafted humanized mice, promoted by TNF-mediated mechanisms. These findings provide evidence that T cell-derived TNF may contribute to the pathogenesis of human hypertension.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antigen-dependent activation of marginal zone B cells amplifies hypertension
Hericka Bruna Figueiredo Galvão, Maria Jelinic, … Antony Vinh·bioRxiv·Oct 17, 2025
- Meningeal IL-17 producing T cells mediate cognitive impairment in salt-sensitive hypertension
Monica M. Santisteban, Samantha M Schaeffer, … Costantino Iadecola·bioRxiv·Sep 5, 2022
- Angiotensin II Infusion Promotes Activation and Selective Cytokine Responses in Activated CD4 and CD8 T cells
Devon A. Dattmore, Jeffrey R. Leipprandt, … Cheryl Elizabeth Rockwell·bioRxiv·Oct 1, 2025
- The Effects of Hypertension on Signaling Dynamics in Rare Renal Cell Types
Justin G McDermott, Bethany L. Goodlett, … Brett M. Mitchell·bioRxiv·Jan 26, 2026
- Adaptive Immunity Governs Regional Aortic Remodeling in Hypertension via Perivascular Adipose Tissue Plasticity
Yiming Xu, J. Caleb Snider, Matthew R. Bersi·bioRxiv·Jul 23, 2025
- Sex differences in cytokine induction by activated T cells from hypertensive BPH/2 and normotensive BPN/3 mice
Devon A. Dattmore, Jeffrey R. Leipprandt, … Cheryl Elizabeth Rockwell·bioRxiv·Sep 30, 2025